President
Tomomi Kawamata
Since our establishment in 1957, Nissin Pharmaceutical has reached a remarkable 70-year milestone, thanks to the continued support of all our stakeholders.
Amid rapid growth in the generic pharmaceutical industry driven by government initiatives, we have adhered to a philosophy of steady, sustainable growth founded on deep trust with medical professionals and patients.
A significant proportion of our leadership team holds technical and scientific backgrounds, driving our dedicated focus on research and development, quality assurance, and robust manufacturing management. We view our role not merely as a manufacturer of generic equivalents, but as a creator of value-added pharmaceuticals--enhancing user-friendliness and patient compliance while preserving the essential efficacy and safety of original drugs. In particular, we are global pioneers in optical sterilization and inspection technologies for polyethylene ampoules, as well as complete containment systems for highly potent pharmaceuticals.
As we look to the future, Nissin Pharmaceutical will continue to serve as a vital pillar of national healthcare, empowering each employee to deliver trustworthy pharmaceuticals with dedication and pride.